[Pharmacological properties of piroxafos (phosphoric ester of piroxicam)].
作者信息
Bianchi A, Amico-Roxas M, Matera M, Mangano O, Trombadore S, Rinaldo G, Caruso A, Puglisi G
出版信息
Farmaco Prat. 1982 Aug;37(8):268-74.
PMID:6982177
Abstract
摘要
相似文献
1
[Pharmacological properties of piroxafos (phosphoric ester of piroxicam)].[吡罗沙星（吡罗昔康磷酸酯）的药理特性]
Farmaco Prat. 1982 Aug;37(8):268-74.
2
[Pharmacologic studies on Ro 12-0068, a new non-steroidal anti-inflammatory drug (author's transl)].
Nihon Yakurigaku Zasshi. 1981 May;77(5):531-52.
3
[Scientific basis of piroxicam (Felden). Pharmacological properties and mechanism of action].[吡罗昔康（费啶）的科学依据。药理特性及作用机制]
Wien Med Wochenschr. 1980;130 Spec No:27-31.
4
The analgetic properties of piroxicam in animals and correlation with experimentally determined plasma levels.吡罗昔康在动物中的镇痛特性及其与实验测定的血浆水平的相关性。
Agents Actions. 1980 Apr;10(1 Pt 2):31-7. doi: 10.1007/BF02024176.
5
Antiinflammatory activity and bioavailability of percutaneous piroxicam.
Arzneimittelforschung. 1982;32(3):230-5.
6
[Action of piroxicam on allergic inflammation].[吡罗昔康对过敏性炎症的作用]
Nihon Yakurigaku Zasshi. 1983 May;81(5):431-40.
7
Endocrine disorders render rats hyporeactive to non-steroidal but not to steroidal anti-inflammatory drugs.内分泌失调使大鼠对非甾体抗炎药反应性降低，但对甾体抗炎药无此反应。
Braz J Med Biol Res. 1985;18(3):341-7.
8
Effect of piroxicam on the chemotaxis and random migration of polymorphonuclear leucocytes after induction of immune and non immune inflammations.
Biomed Pharmacother. 1985;39(7):381-5.
9
What piroxicam does and why.吡罗昔康的作用及原理。
Eur J Rheumatol Inflamm. 1983;6(1):1-2.
10
Second piroxicam symposium.第二届吡罗昔康研讨会
Eur J Rheumatol Inflamm. 1983;6(1):1-138.
Zotero 插件